JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB75501

Anti-GPCR GPR48/LGR4 antibody

5

(1 Review)

|

(6 Publications)

Rabbit Polyclonal GPCR GPR48/LGR4 antibody. Suitable for WB and reacts with Human samples. Cited in 6 publications.

View Alternative Names

GPR48, LGR4, Leucine-rich repeat-containing G-protein coupled receptor 4, G-protein coupled receptor 48

1 Images
Western blot - Anti-GPCR GPR48/LGR4 antibody (AB75501)
  • WB

Unknown

Western blot - Anti-GPCR GPR48/LGR4 antibody (AB75501)

All lanes:

Western blot - Anti-GPCR GPR48/LGR4 antibody (ab75501) at 1/500 dilution

Lane 1:

Jurkat cell extract at 30 µg

Lane 2:

Jurkat cell extract at 30 µg with immunising peptide

Predicted band size: 104 kDa

Observed band size: 104 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific immunogen.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GPR48 also known as LGR4 is a member of the G protein-coupled receptor (GPCR) family. This receptor has a known molecular mass of approximately 105 kDa. It is expressed in various tissues including the liver kidneys intestines and reproductive organs. LGR4 is part of the large family of leucine-rich repeat-containing GPCRs and functions through the activation of distinct downstream signaling pathways which eventually lead to cellular responses important for physiological processes.
Biological function summary

The receptor engages in a wide range of functions through its interactions with specific ligands influencing cell proliferation differentiation and survival. LGR4 does not act alone but forms complexes with other receptors or signaling molecules to perform specific activities. It significantly impacts the development of the reproductive system and plays a role in bone formation and remodeling. The receptor contributes to cellular signaling that drives essential biological processes by modulating the activity of various downstream components.

Pathways

The LGR4 receptor is actively involved in the Wnt signaling pathway and RANKL pathway both essential pathways for development and tissue homeostasis. Within the Wnt signaling pathway LGR4 interacts with proteins like LRP6 and Frizzled receptors to regulate gene expression and cellular proliferation. In the RANKL pathway it orchestrates osteoclast differentiation which is important for bone metabolism. The receptor's ability to modulate these pathways highlights its intricate role in maintaining cellular and structural integrity in the body.

Aberrations in LGR4 signaling have associations with various conditions such as osteoporosis and cancer. In osteoporosis disrupted signaling affects bone density and strength leading to increased fracture risk. In cancers altered LGR4 function or expression can contribute to tumorigenesis impacting cancer progression and metastasis. The receptor can relate to proteins such as RANK and RANKL in bone diseases and interacts with other signaling molecules to affect cancer pathways suggesting its potential as a therapeutic target in these disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor for R-spondins that potentiates the canonical Wnt signaling pathway and is involved in the formation of various organs. Upon binding to R-spondins (RSPO1, RSPO2, RSPO3 or RSPO4), associates with phosphorylated LRP6 and frizzled receptors that are activated by extracellular Wnt receptors, triggering the canonical Wnt signaling pathway to increase expression of target genes. In contrast to classical G-protein coupled receptors, does not activate heterotrimeric G-proteins to transduce the signal. Its function as activator of the Wnt signaling pathway is required for the development of various organs, including liver, kidney, intestine, bone, reproductive tract and eye. May also act as a receptor for norrin (NDP), such results however require additional confirmation in vivo. Required during spermatogenesis to activate the Wnt signaling pathway in peritubular myoid cells. Required for the maintenance of intestinal stem cells and Paneth cell differentiation in postnatal intestinal crypts. Acts as a regulator of bone formation and remodeling. Involved in kidney development; required for maintaining the ureteric bud in an undifferentiated state. Involved in the development of the anterior segment of the eye. Required during erythropoiesis. Also acts as a negative regulator of innate immunity by inhibiting TLR2/TLR4 associated pattern-recognition and pro-inflammatory cytokine production. Plays an important role in regulating the circadian rhythms of plasma lipids, partially through regulating the rhythmic expression of MTTP (By similarity). Required for proper development of GnRH neurons (gonadotropin-releasing hormone expressing neurons) that control the release of reproductive hormones from the pituitary gland (By similarity).
See full target information LGR4

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:4393 PubMed38782937

2024

Reduction of specific enterocytes from loss of intestinal LGR4 improves lipid metabolism in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Liang,Chao Luo,Lijun Sun,Tiange Feng,Wenzhen Yin,Yunhua Zhang,Michael W Mulholland,Weizhen Zhang,Yue Yin

Bone 176:116866 PubMed37558192

2023

G-protein coupled receptor 5C (GPRC5C) is required for osteoblast differentiation and responds to EZH2 inhibition and multiple osteogenic signals.

Applications

Unspecified application

Species

Unspecified reactive species

Parisa Dashti,Roman Thaler,John R Hawse,M Lizeth Galvan,Bram J van der Eerden,Andre J van Wijnen,Amel Dudakovic

Journal of oncology 2022:1774095 PubMed36385965

2022

Metformin Suppresses Hepatocellular Carcinoma through Regulating Alternative Splicing of LGR4.

Applications

Unspecified application

Species

Unspecified reactive species

Han Zhuo,Shuying Miao,Zhenquan Jin,Deming Zhu,Zhenggang Xu,Dongwei Sun,Jie Ji,Zhongming Tan

iScience 25:105184 PubMed36217544

2022

RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation.

Applications

Unspecified application

Species

Unspecified reactive species

Rulu Pan,Yan Yu,Haiyan Zhu,Wenyi Zhang,Yuan Qin,Lin Ye,Juji Dai,Ren Huang,Xinyan Peng,Siqi Ye,Ziqi Lin,Shishun Huang,Shuyi Chong,Liting Lu,Xincheng Lu

Genetics and molecular biology 45:e20210322 PubMed36121915

2022

MiR-137-mediated negative relationship between LGR4 and RANKL modulated osteogenic differentiation of human adipose-derived mesenchymal stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Cong Fan,Yulong Li

Cancer cell 38:263-278.e6 PubMed32559496

2020

Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Basit Salik,Hangyu Yi,Nunki Hassan,Nancy Santiappillai,Binje Vick,Patrick Connerty,Alastair Duly,Toby Trahair,Andrew J Woo,Dominik Beck,Tao Liu,Karsten Spiekermann,Irmela Jeremias,Jianlong Wang,Maria Kavallaris,Michelle Haber,Murray D Norris,Dan A Liebermann,Richard J D'Andrea,Christopher Murriel,Jenny Y Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com